BridgeBio Pharma (BBIO) Stock Price, Quote, News & History | Benzinga

BridgeBio Pharma Inc (BBIO) Stock Price, Quote, News & History

BBIONASDAQ

Trade with Public

Trade with Public

$63.28

-2.08-3.18%

Last update: Jun 2, 12:49 PM

OverviewNews Earnings Events Options Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$64.85

Close

-

Volume / Avg.

1.17M / 2.50M

Day Range

$62.50 - $65.08

52 Wk Range

32.37 - 84.94

Market Cap

$12.39B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

38

Short Interest

13.77%

Days to Cover

8.73

Recent BridgeBio Pharma Inc News

BridgeBio Pharma Eyes First Treatment For Rare Muscle Disorder As Trial Data Shows Early Progress

BridgeBio Pharma shares Phase 3 trial update, but early data show progress for rare muscle disease treatment.

Vandana Singh

BridgeBio's Rare-Disease Pipeline Sparks Growth Buzz

BridgeBio's rare-disease pipeline draws investor attention as new therapies near regulatory filings and potential commercial launches.

Vandana Singh

Blue Owl, Genuine Parts, And Okta Are Among Top 10 Large Cap Losers Last Week (Feb. 16-Feb. 20): Are the Others in Your Portfolio?

Ten large-cap stocks sank last week as weak earnings, lowered guidance, analyst downgrades, and deal-related headlines weighed on shares.

Nabaparna Bhattacharya

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-443.95M

Investing Cash Flow (TTM)

-65.63M

Financing Cash Flow (TTM)

848.86M

Free Cash Flow (TTM)

-452.02M

Capital Expenditure (TTM)

-8.07M

Net Change in Cash (TTM)

339.28M

Analyst Trends and Forecast

7

Feb

3

Mar

5

Apr

4

2

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$14.35B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

21.72

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-5.72%

Earnings Yield % (FWD)

-2.31%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$11.63

Company Debt

Total Debt

$2.47B

LT Debt

$1.93B

LT Debt Issuance (TTM)

$632.50M

LT Debt Repayment (TTM)

$0

Total Cash

$879.89M

Debt to Equity

-

Issuance of Debt (TTM)

$632.50M

Repayment of Debt (TTM)

$0

Key Statistics

Open

$64.85

Close

-

Volume / Avg.

1.17M / 2.50M

Day Range

$62.50 - $65.08

52 Wk Range

32.37 - 84.94

Market Cap

$12.39B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

38

Short Interest

13.77%

Days to Cover

8.73

About

Sector

Health Care

Industry

Biotechnology

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disor...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy BridgeBio Pharma (BBIO) stock?

A

You can purchase shares of BridgeBio Pharma (NASDAQ:BBIO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are BridgeBio Pharma (BBIO) competitors?

A

There are no as such competitors for BridgeBio Pharma.

Q

What is the forecast, or price target, for BridgeBio Pharma (BBIO) stock?

A

BridgeBio Pharma has a consensus price target of $85.77.

Q

What is the current price for BridgeBio Pharma (BBIO)?

A

The stock price for BridgeBio Pharma (NASDAQ: BBIO) is $63.28 last updated June 2, 2026 at 12:49 PM EDT.

Q

Does BridgeBio Pharma (BBIO) pay a dividend?

A

There are no upcoming dividends for BridgeBio Pharma.

Q

When is BridgeBio Pharma (NASDAQ:BBIO) reporting earnings?

A

BridgeBio Pharma does not have any upcoming earnings scheduled.

Q

Is BridgeBio Pharma (BBIO) going to split?

A

There is no upcoming split for BridgeBio Pharma.

Q

What sector and industry does BridgeBio Pharma (BBIO) operate in?

A

BridgeBio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.